GLP-1 can effectively alleviate the symptoms of AD, which may be related to increasing the level of growth factors that protect the function of nerve cells in the brain, reducing the level of chronic inflammation and oxidative stress in the brain, and alleviating the rate of nerve loss (Tai et al., 2018; Zhao et al., 2021). This evidence concerns the gene GCG and Alzheimer disease.